These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29956165)

  • 21. Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells.
    Santos DP; Kiskinis E; Eggan K; Merkle FT
    Curr Protoc Stem Cell Biol; 2016 Aug; 38():5B.6.1-5B.6.60. PubMed ID: 27532820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous Gene Excision and Integration by Dual-Guide CRISPR-Cas9.
    Spagnuolo M; Blenner M
    Methods Mol Biol; 2021; 2307():69-83. PubMed ID: 33847982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9-Mediated Gene Knockout in Cells and Tissues Using Lentivirus.
    Lu J; Wang S
    Curr Protoc; 2023 May; 3(5):e772. PubMed ID: 37222511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Easy quantification of template-directed CRISPR/Cas9 editing.
    Brinkman EK; Kousholt AN; Harmsen T; Leemans C; Chen T; Jonkers J; van Steensel B
    Nucleic Acids Res; 2018 Jun; 46(10):e58. PubMed ID: 29538768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysing the outcome of CRISPR-aided genome editing in embryos: Screening, genotyping and quality control.
    Mianné J; Codner GF; Caulder A; Fell R; Hutchison M; King R; Stewart ME; Wells S; Teboul L
    Methods; 2017 May; 121-122():68-76. PubMed ID: 28363792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-Directed Genome Knockout in Chicken Cell Line and Embryos Can Use CRISPR/Cas Gene Editing Technology.
    Zuo Q; Wang Y; Cheng S; Lian C; Tang B; Wang F; Lu Z; Ji Y; Zhao R; Zhang W; Jin K; Song J; Zhang Y; Li B
    G3 (Bethesda); 2016 Jun; 6(6):1787-92. PubMed ID: 27172204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted Transgenic Mice Using CRISPR /Cas9 Technology.
    El Marjou F; Jouhanneau C; Krndija D
    Methods Mol Biol; 2021; 2214():125-141. PubMed ID: 32944907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of Genetically Modified Mice Using CRISPR/Cas9.
    Muñoz-Santos D; Montoliu L; Fernández A
    Methods Mol Biol; 2020; 2110():129-138. PubMed ID: 32002906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo.
    Chang H; Yi B; Ma R; Zhang X; Zhao H; Xi Y
    Sci Rep; 2016 Feb; 6():22312. PubMed ID: 26924382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR-Cas9 Genome Editing in Human Cell Lines with Donor Vector Made by Gibson Assembly.
    Sahoo N; Cuello V; Udawant S; Litif C; Mustard JA; Keniry M
    Methods Mol Biol; 2020; 2115():365-383. PubMed ID: 32006411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene Disruption Using CRISPR-Cas9 Technology.
    Hu N; Malek SN
    Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
    Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K
    Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9.
    Ceasar SA; Rajan V; Prykhozhij SV; Berman JN; Ignacimuthu S
    Biochim Biophys Acta; 2016 Sep; 1863(9):2333-44. PubMed ID: 27350235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR-Cas9: A fascinating journey from bacterial immune system to human gene editing.
    Hossain MA
    Prog Mol Biol Transl Sci; 2021; 178():63-83. PubMed ID: 33685600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pooled Lentiviral CRISPR-Cas9 Screens for Functional Genomics in Mammalian Cells.
    Aregger M; Chandrashekhar M; Tong AHY; Chan K; Moffat J
    Methods Mol Biol; 2019; 1869():169-188. PubMed ID: 30324523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
    Basila M; Kelley ML; Smith AVB
    PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Microbial Modification Tools to Convert Lipids into Other Value-Added Products.
    Kumari P; Yusuf F; Gaur NA
    Methods Mol Biol; 2019; 1995():161-171. PubMed ID: 31148128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome editing with the donor plasmid equipped with synthetic crRNA-target sequence.
    Ishibashi R; Abe K; Ido N; Kitano S; Miyachi H; Toyoshima F
    Sci Rep; 2020 Aug; 10(1):14120. PubMed ID: 32839482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple protocol to isolate a single human cell PRDX1 knockout generated by CRISPR-Cas9 system.
    Aouida M; Aljogol D; Ali R; Ramotar D
    STAR Protoc; 2022 Mar; 3(1):101216. PubMed ID: 35284843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR mediated genome editing, a tool to dissect RNA modification processes.
    Pickerill ES; Bernstein DA
    Methods Enzymol; 2021; 658():435-452. PubMed ID: 34517958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.